Patents by Inventor Jongsu KYUNG

Jongsu KYUNG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition comprising a combined herb extract of and red ginseng as active ingredients for preventing or treating a respiratory inflammation and the use thereof
    Patent number: 11510955
    Abstract: The present invention relates to a composition and health functional food for preventing and treating a respiratory inflammation disease using a mixed herbal mixture. Through various experiments, for example, determination of the cell number of BAL (bronchoalveolar lavage) (Experimental Example 1); Determination of CD11b+/Gr-1+ ratio in leukocyte within BAL fluid (Experimental Example 2); Determination of expressed RNA level of inflammatory cytokines in lung tissue (Experimental Example 3); Determination of expressed RNA level of inflammatory cytokines in BALF (Experimental Example 4); Lung histology (Experimental Example 5); Brief Clinical test (Experimental Example 7) etc, it has been verified that the inventive combined extract showed more potent inhibiting effect on respiratory inflammation disease than each herb extract.
    Type: Grant
    Filed: May 10, 2018
    Date of Patent: November 29, 2022
    Assignees: KT&G CORPORATION, KOREA GINSENG CORP.
    Inventors: Han-Jae Shin, Hyo Keun Kim, Moon-Yong Lee, Hyo-Min Gwak, Hye-Jeong Min, Young-Sin Kim, Chang Kyun Han, Jongsu Kyung, Gyo In, Jong Han Kim, Sung Won Kim, Kyoung Hwa Jang, Seung-Hyung Kim
  • COMPOSITION COMPRISING A COMBINED HERB EXTRACT OF SALVIA PLEBIA AND RED GINSENG AS ACTIVE INGREDIENTS FOR PREVENTING OR TREATING A RESPIRATORY INFLAMMATION AND THE USE THEREOF
    Publication number: 20200164016
    Abstract: The present invention relates to a composition and health functional food for preventing and treating a respiratory inflammation disease using a mixed herbal mixture. Through various experiments, for example, determination of the cell number of BAL (bronchoalveolar lavage) (Experimental Example 1); Determination of CD11b+/Gr-1+ ratio in leukocyte within BAL fluid (Experimental Example 2); Determination of expressed RNA level of inflammatory cytokines in lung tissue (Experimental Example 3); Determination of expressed RNA level of inflammatory cytokines in BALF (Experimental Example 4); Lung histology (Experimental Example 5); Brief Clinical test (Experimental Example 7) etc, it has been verified that the inventive combined extract showed more potent inhibiting effect on respiratory inflammation disease than each herb extract.
    Type: Application
    Filed: May 10, 2018
    Publication date: May 28, 2020
    Inventors: Han-Jae SHIN, Hyo Keun KIM, Moon-Yong LEE, Hyo-Min GWAK, Hye-Jeong MIN, Young-Sin KIM, Chang Kyun HAN, Jongsu KYUNG, Gyo IN, Jong Han KIM, Sung Won KIM, Kyoung Hwa JANG, Seung-Hyung KIM